152 related articles for article (PubMed ID: 37169873)
1. CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses.
Yang Z; Wang C; Liu L; Khan A; Lee A; Vardarajan B; Mayeux R; Kiryluk K; Ionita-Laza I
Nat Genet; 2023 Jun; 55(6):1057-1065. PubMed ID: 37169873
[TBL] [Abstract][Full Text] [Related]
2. Genetic fine-mapping from summary data using a nonlocal prior improves the detection of multiple causal variants.
Karhunen V; Launonen I; Järvelin MR; Sebert S; Sillanpää MJ
Bioinformatics; 2023 Jul; 39(7):. PubMed ID: 37348543
[TBL] [Abstract][Full Text] [Related]
3. Improving the coverage of credible sets in Bayesian genetic fine-mapping.
Hutchinson A; Watson H; Wallace C
PLoS Comput Biol; 2020 Apr; 16(4):e1007829. PubMed ID: 32282791
[TBL] [Abstract][Full Text] [Related]
4. SparsePro: An efficient fine-mapping method integrating summary statistics and functional annotations.
Zhang W; Najafabadi H; Li Y
PLoS Genet; 2023 Dec; 19(12):e1011104. PubMed ID: 38153934
[TBL] [Abstract][Full Text] [Related]
5. The flashfm approach for fine-mapping multiple quantitative traits.
Hernández N; Soenksen J; Newcombe P; Sandhu M; Barroso I; Wallace C; Asimit JL
Nat Commun; 2021 Oct; 12(1):6147. PubMed ID: 34686674
[TBL] [Abstract][Full Text] [Related]
6. Incorporating Functional Annotations for Fine-Mapping Causal Variants in a Bayesian Framework Using Summary Statistics.
Chen W; McDonnell SK; Thibodeau SN; Tillmans LS; Schaid DJ
Genetics; 2016 Nov; 204(3):933-958. PubMed ID: 27655946
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis.
Li X; Sham PC; Zhang YD
Am J Hum Genet; 2024 Feb; 111(2):213-226. PubMed ID: 38171363
[TBL] [Abstract][Full Text] [Related]
8. Genetic associations at regulatory phenotypes improve fine-mapping of causal variants for 12 immune-mediated diseases.
Kundu K; Tardaguila M; Mann AL; Watt S; Ponstingl H; Vasquez L; Von Schiller D; Morrell NW; Stegle O; Pastinen T; Sawcer SJ; Anderson CA; Walter K; Soranzo N
Nat Genet; 2022 Mar; 54(3):251-262. PubMed ID: 35288711
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Performance of Fine-Mapping Strategies at Common Variant GWAS Loci.
van de Bunt M; Cortes A; ; Brown MA; Morris AP; McCarthy MI
PLoS Genet; 2015; 11(9):e1005535. PubMed ID: 26406328
[TBL] [Abstract][Full Text] [Related]
10. Trans-ethnic meta-regression of genome-wide association studies accounting for ancestry increases power for discovery and improves fine-mapping resolution.
Mägi R; Horikoshi M; Sofer T; Mahajan A; Kitajima H; Franceschini N; McCarthy MI; ; Morris AP
Hum Mol Genet; 2017 Sep; 26(18):3639-3650. PubMed ID: 28911207
[TBL] [Abstract][Full Text] [Related]
11. A Scalable Bayesian Method for Integrating Functional Information in Genome-wide Association Studies.
Yang J; Fritsche LG; Zhou X; Abecasis G;
Am J Hum Genet; 2017 Sep; 101(3):404-416. PubMed ID: 28844487
[TBL] [Abstract][Full Text] [Related]
12. Integration of expression QTLs with fine mapping via SuSiE.
Zhang X; Jiang W; Zhao H
PLoS Genet; 2024 Jan; 20(1):e1010929. PubMed ID: 38271473
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential genetic causal variants for obesity-related traits using statistical fine mapping.
Gong R; Greenbaum J; Lin X; Du Y; Su KJ; Gong Y; Shen J; Deng HW
Mol Genet Genomics; 2023 Nov; 298(6):1309-1319. PubMed ID: 37498361
[TBL] [Abstract][Full Text] [Related]
14. Effect of all-but-one conditional analysis for eQTL isolation in peripheral blood.
Brown M; Greenwood E; Zeng B; Powell JE; Gibson G
Genetics; 2023 Jan; 223(1):. PubMed ID: 36321965
[TBL] [Abstract][Full Text] [Related]
15. Integrating functional data to prioritize causal variants in statistical fine-mapping studies.
Kichaev G; Yang WY; Lindstrom S; Hormozdiari F; Eskin E; Price AL; Kraft P; Pasaniuc B
PLoS Genet; 2014 Oct; 10(10):e1004722. PubMed ID: 25357204
[TBL] [Abstract][Full Text] [Related]
16. Stochastic search and joint fine-mapping increases accuracy and identifies previously unreported associations in immune-mediated diseases.
Asimit JL; Rainbow DB; Fortune MD; Grinberg NF; Wicker LS; Wallace C
Nat Commun; 2019 Jul; 10(1):3216. PubMed ID: 31324808
[TBL] [Abstract][Full Text] [Related]
17. An efficient multi-locus mixed-model approach for genome-wide association studies in structured populations.
Segura V; Vilhjálmsson BJ; Platt A; Korte A; Seren Ü; Long Q; Nordborg M
Nat Genet; 2012 Jun; 44(7):825-30. PubMed ID: 22706313
[TBL] [Abstract][Full Text] [Related]
18. Multiple SNP Set Analysis for Genome-Wide Association Studies Through Bayesian Latent Variable Selection.
Lu ZH; Zhu H; Knickmeyer RC; Sullivan PF; Williams SN; Zou F;
Genet Epidemiol; 2015 Dec; 39(8):664-77. PubMed ID: 26515609
[TBL] [Abstract][Full Text] [Related]
19. Integrating molecular QTL data into genome-wide genetic association analysis: Probabilistic assessment of enrichment and colocalization.
Wen X; Pique-Regi R; Luca F
PLoS Genet; 2017 Mar; 13(3):e1006646. PubMed ID: 28278150
[TBL] [Abstract][Full Text] [Related]
20. Bayesian analysis of genome-wide inflammatory bowel disease data sets reveals new risk loci.
Zhang Y; Tian L; Sleiman P; Ghosh S; Hakonarson H;
Eur J Hum Genet; 2018 Feb; 26(2):265-274. PubMed ID: 29203833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
